Amaero Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMROF research report →
Price Chart
About the company
Amaero Ltd manufactures and sells refractory, specialty alloys, and powders for additive manufacturing of mission-critical components in the United States. It serves defense, aerospace, oil and gas, energy, nuclear, space, aviation, and medical and industrial industries. The company was formerly known as Amaero International Limited and changed its name to Amaero Ltd in April 2025.
- CEO
- Hank Jarrett Holland
- IPO
- 2021
- Employees
- 21,143
- HQ
- Mcdonald, TN, US
Get TickerSpark's AI analysis on AMROF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $149.34M
- P/E
- -4.84
- Fwd P/E
- 20.39
- PEG
- -0.54
- P/S
- 11.86
- P/B
- 1.79
- EV/EBITDA
- -4.68
- Div Yield
- 0.00%
- Gross Margin
- -52.64%
- Op Margin
- -281.42%
- Net Margin
- -289.50%
- ROE
- -39.81%
- ROIC
- -21.09%
Latest fiscal year · YoY change
- Revenue
- $2.51M+441.0%
- Gross Profit
- $-964,844-876.5%
- Op Income
- $-15,611,651
- Net Income
- $-16,081,963+14.4%
- EPS
- $-0.03+33.1%
- OCF Growth
- +11.0%
- FCF Growth
- -13.4%
- 52W High
- $0.46
- 52W Low
- $0.14
- 50D MA
- $0.26
- 200D MA
- $0.22
- Beta
- 0.84
- RSI (14)
- 45
- Avg Volume
- 57.35K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Amaero said Q3 was in line with expectations, with 301% year-over-year revenue growth and reaffirmed FY26 guidance of $18 million to $20 million, while highlighting a strong Q4 and increasing U.S. strategic momentum.· April 20, 2026
- Q3 revenue was $2.6 million, up 301% year over year, with $1.8 million from powder sales and $0.7 million from PM-HIP.
- FY26 revenue guidance was reaffirmed at $18 million to $20 million, and management said over $18 million is already fully contracted.
- Q4 looks like a step-change quarter, with $8.4 million of contracted revenue and expectations for titanium revenue to rise 62% versus Q3.
- Cash ended at $38.3 million, including $4.9 million restricted cash; pro forma cash rises to $44.1 million after the expected $5.8 million EXIM reimbursement.
- Management emphasized U.S. re-domiciliation, a possible U.S. listing, and access to classified defense work as key strategic priorities.
Amaero reported Q3 FY26 revenue of $2.6 million, up 301% year over year, with $1.8 million from powder sales and $0.7 million from PM-HIP. Trailing 12-month revenue reached $11.8 million, up 347% year over year. Trailing 12-month G&A expense increased 18% year over year. The company ended Q3 with $38.3 million in cash, including $4.9 million restricted cash; pro forma cash is $44.1 million after expected receipt of a $5.8 million EXIM Bank disbursement. FY26 revenue guidance was reaffirmed at $18 million to $20 million, with over $18 million said to be fully contracted. For Q4, management said it has $8.4 million in contracted revenue and expects a significant inflection in quarterly revenue. Management also said the EXIM Bank loan commitment was increased from USD 22.8 million to USD 26.1 million, a USD 3.3 million increase.
Hank Holland framed the quarter as proof that Amaero is reaching an inflection point, with revenue scaling rapidly while G&A growth remains restrained. He emphasized the company’s shift from building capability to scaling it, citing long-term contracts, full utilization of the titanium atomizer this quarter, and strong visibility into FY27. His tone was confident and strategic, centered on Amaero’s role in U.S. defense industrial base, critical minerals, and sovereign manufacturing.
No separate CFO spoke; Hank Holland covered the financials. He cited Q3 cash of $38.3 million including $4.9 million restricted cash, net cash used in operations of $7.1 million, inventory purchases of $0.6 million, CapEx of $5.4 million, and an FX impact of $1.2 million. He also highlighted the $5.8 million EXIM draw request, the increase in EXIM loan commitment to USD 26.1 million, and the contrast between 347% trailing 12-month revenue growth and 18% trailing 12-month G&A growth as evidence of operating leverage.
Analysts focused on how Amaero converted pipeline into contracted revenue, and management said contracting accelerated after the U.S. government reopened, with further visibility coming from a $7.8 million FY27 titanium contract and a planned refractory development contract. Questions also covered energy costs, where management said it is insulated by a 10-year subsidized electricity agreement at $0.058/kWh, and supply chain resilience, where management said titanium is secure but pricing remains a concern, while niobium is not a worry. Other questions addressed FOCI requirements and government support; Holland said multiple programs are advancing with multiple defense primes and that U.S. re-domiciliation supports access to classified contracts, but he was careful not to speculate on government equity stakes.
The bull case from this call is that Amaero appears to have moved into a visible revenue ramp, with Q4 fully contracted and FY26 already largely locked in. Management also pointed to a growing U.S.-aligned strategic position, including re-domiciliation, possible U.S. listing, EXIM-backed financing, and progress toward classified defense opportunities.
The main risks raised were execution and qualification risk: PM-HIP contracts have longer sales cycles and classified defense opportunities still require FOCI and facility approvals. Management also flagged input cost pressure in certain materials such as hafnium, zirconium, and tungsten, plus the fact that current growth depends on successfully scaling production and completing major strategic steps on schedule.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 56.9%
- Shares Outstanding
- 635.50M
- Float Shares
- 361.68M
Our AMROF coverage
Recent articles, reports, and earnings notes.
No research on AMROF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AMROF report →Amaero Provides Board Update
globenewswire.com · Aug 5
Amaero Releases Quarterly Activities Report for the Period Ending June 2026
globenewswire.com · Jul 22
Amaero Resumes Titanium Powder Production
globenewswire.com · Jul 9
Amaero Re-domiciliation: Schemes Become Effective
globenewswire.com · Jun 11
Amaero Shares Investor Briefing Recording
globenewswire.com · Apr 22
Amaero Ltd (AMROF) Q3 2026 Earnings Call Transcript
seekingalpha.com · Apr 21
Q3 FY2026 Investor Webinar
globenewswire.com · Apr 16
Novo Nordisk's GLP-1 pill momentum faces pricing test, says leading bank
proactiveinvestors.com · Apr 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.